Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jun 1;26(6):e759-e772.
doi: 10.1097/PCC.0000000000003743. Epub 2025 Apr 25.

The Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA) Study in Mechanically Ventilated Children: Prospective Multicenter Epidemiology in Spain, 2019-2021

Collaborators, Affiliations
Observational Study

The Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA) Study in Mechanically Ventilated Children: Prospective Multicenter Epidemiology in Spain, 2019-2021

Yolanda M López-Fernández et al. Pediatr Crit Care Med. .

Abstract

Objectives: To describe the epidemiology and outcome of children with acute hypoxemic respiratory failure (AHRF) and/or pediatric acute respiratory distress syndrome (PARDS).

Design: Prospective, observational study in six nonconsecutive 2-month blocks form October 2019 to September 2021.

Setting: A network of 22 PICUs in Spain.

Patients: Consecutive children (7 d to 15 yr old) with a diagnosis of AHRF, defined by Pa o2 /F io2 ratio less than or equal to 300 mm Hg, who needed invasive mechanical ventilation (IMV) using positive end-expiratory pressure (PEEP) greater than or equal to 5 cm H 2 O and F io2 greater than or equal to 0.3.

Interventions: None.

Measurements and main results: The primary outcomes were AHRF prevalence and PICU mortality. The secondary outcomes were the prevalence of IMV with PARDS (IMV-PARDS) and the use of adjunctive therapies. There were 6545 PICU admissions: 1374 (21%) underwent IMV and 181 (2.8%) had AHRF. Ninety-one patients (1.4% of PICU admissions, 6.6% of IMV cases, and 50.3% of AHRF cases) met the Second Pediatric Acute Lung Injury Consensus Conference IMV-PARDS criteria. At baseline, mean (± sd ) tidal volume was 7.4 ± 1.8 mL/kg ideal body weight, PEEP 8.4 ± 3.1 cm H 2 O, F io2 0.68 ± 0.23, and plateau pressure 25.7 ± 6.3 cm H 2 O. Unlike patients with PARDS, adjunctive therapies were used infrequently in non-PARDS AHRF patients. AHRF patients without PARDS had more ventilator-free days than PARDS patients (16.4 ± 9.4 vs. 11.2 ± 10.5; p = 0.002). All-cause PICU mortality in AHRF cases was higher in PARDS vs. non-PARDS patients (30.8% [95% CI, 21.5-41.3] vs. (14.4% [95% CI, 7.9-23.4]; p = 0.01).

Conclusions: In our 2019-2021 PICU population, the prevalence of AHRF is 2.8% of IMV cases. Of such patients, the prevalence of PARDS was 50.3%, and there was a 30.8% mortality, which was higher than in cases of AHRF without PARDS.

Trial registration: ClinicalTrials.gov NCT04791501.

Keywords: acute hypoxemic respiratory failure; acute respiratory distress syndrome; children; epidemiology; lung-protective ventilation.

PubMed Disclaimer

Conflict of interest statement

Dr. López-Fernández received a grant from Instituto de Salud Carlos III, Madrid, Spain (PI19/00141). Dr. Villar received grants from Instituto de Salud Carlos III, Madrid, Spain (No. CB06/06/1088, PI19/00141, AC_212/00039), ERA PerMed (JTC_2021), The European Regional Development Funds, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Spain, and Asociación Científica Pulmón y Ventilación Mecánica, Spain. Dr. Gómez-Zamora received funding from AEROGEN(R). Dr. Szakmany has disclosed that he is Trustee of the Intensive Care National Audit and Research Centre (United Kingdom) Congress Co-Chair 2024 Society of Critical Care Medicine Congress. The remaining authors have disclosed that they do not have any potential conflicts of interest.

References

    1. World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013; 310:2191–2194
    1. von EE, Altman DG, Egger M, et al.: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ. 2007; 335:806–808
    1. Emeriaud G, López-Fernández YM, Lyer NP, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) Group on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2). Pediatr Crit Care Med. 2023; 24:143–168
    1. Grunwell JR, Dahmer MK, Sapru A, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) for the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Pathobiology, severity, and risk stratification of pediatric acute respiratory distress syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2023; 24:S12–S27
    1. Killien EY, Maddux AB, Tse SM, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Outcomes of children surviving pediatric acute respiratory distress syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2023; 24:S28–S44

Publication types

MeSH terms

Associated data